Suven Life Sciences was locked at 5% upper limit at Rs 25.85 at 11:28 IST on BSE, after the company secured three European patents on new chemical entities.
Suven Life Sciences jumped 19.92% to Rs 31.60 at 10:00 IST on BSE, after the company said it is in talks with four global Pharma major for out-licensing deals for its Alzheimer drug SUVN-502, which is in the developing stage.